Skip to main content

26.03.2024 | Review

A scoping review of triage approaches for the referral of patients with suspected inflammatory arthritis, from primary to rheumatology care

verfasst von: Norma K. Biln, Nick Bansback, Kam Shojania, Lorri Puil, Mark Harrison

Erschienen in: Rheumatology International

Einloggen, um Zugang zu erhalten

Abstract

We aimed to (1) identify existing triage approaches for referral of patients with suspected inflammatory arthritis (IA) from primary care physicians (PCP) to rheumatologists, (2) describe their characteristics and methodologies for clinical use, and (3) report their level of validation for use in a publicly funded healthcare system. The comprehensive search strategy of multiple databases up to October 2023 identified relevant literature and focussed on approaches applied at the PCP–Rheumatologist referral stage. Primary, quantitative studies, reported in English were included. Triage approaches were grouped into patient conditions as defined by the authors of the reports, including IA, its subtypes and combinations. 13952 records were identified, 425 full text reviewed and 55 reports of 53 unique studies were included. Heterogeneity in disease nomenclature and study sample pretest probability was found. The number of published studies rapidly increased after 2012. Studies were mostly from Europe and North America, in IA and Axial Spondyloarthritis (AxSpa). We found tools ranging the continuum of development with those best performing, indicated by the area under the receiver operating curve (AUC) >0.8), requiring only patient-reported questions. There were AUCs for some tools reported from multiple studies, these were in the outstanding to excellent range for the Early IA Questionnaire (EIAQ) (0.88 to 0.92), acceptable for the Case Finding AxSpa (CaFaSpa) (0.70 to 0.75), and poor to outstanding for the Psoriasis Epidemiology Screening Tool (PEST) (0.61 to 0.91). Given the clinical urgency to improve rheumatology referrals and considering the good
Anhänge
Nur mit Berechtigung zugänglich
Literatur
8.
Zurück zum Zitat Simons G, Belcher J, Morton C et al (2017) Symptom recognition and perceived urgency of help-seeking for rheumatoid arthritis and other diseases in the general public: a mixed method approach: role of symptom recognition in help-seeking for RA. Arthritis Care Res 69:633–641. https://doi.org/10.1002/acr.22979CrossRef Simons G, Belcher J, Morton C et al (2017) Symptom recognition and perceived urgency of help-seeking for rheumatoid arthritis and other diseases in the general public: a mixed method approach: role of symptom recognition in help-seeking for RA. Arthritis Care Res 69:633–641. https://​doi.​org/​10.​1002/​acr.​22979CrossRef
12.
Zurück zum Zitat Badley EM, Mayilee C, Gunz AC, Davis AM (2015) Visits to rheumatologists for arthritis: the role of access to primary care physicians, geographic availability of rheumatologists, and socioeconomic status. Arthritis Care Res 67:230–239. https://doi.org/10.1002/acr.22413CrossRef Badley EM, Mayilee C, Gunz AC, Davis AM (2015) Visits to rheumatologists for arthritis: the role of access to primary care physicians, geographic availability of rheumatologists, and socioeconomic status. Arthritis Care Res 67:230–239. https://​doi.​org/​10.​1002/​acr.​22413CrossRef
24.
47.
Zurück zum Zitat Ibrahim GH, Buch MH, Lawson C, et al (2009) Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. 27:469–474. https://pubmed.ncbi.nlm.nih.gov/19604440/ Ibrahim GH, Buch MH, Lawson C, et al (2009) Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. 27:469–474. https://​pubmed.​ncbi.​nlm.​nih.​gov/​19604440/​
58.
75.
Zurück zum Zitat van Delft ETAM, Barreto DL, van der Helm-van Mil AHM et al (2022) Diagnostic performance and clinical utility of referral rules to identify primary care patients at risk of an inflammatory rheumatic disease. Arthritis Care Res 74:2100–2107. https://doi.org/10.1002/acr.24789CrossRef van Delft ETAM, Barreto DL, van der Helm-van Mil AHM et al (2022) Diagnostic performance and clinical utility of referral rules to identify primary care patients at risk of an inflammatory rheumatic disease. Arthritis Care Res 74:2100–2107. https://​doi.​org/​10.​1002/​acr.​24789CrossRef
Metadaten
Titel
A scoping review of triage approaches for the referral of patients with suspected inflammatory arthritis, from primary to rheumatology care
verfasst von
Norma K. Biln
Nick Bansback
Kam Shojania
Lorri Puil
Mark Harrison
Publikationsdatum
26.03.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-024-05575-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.